Correlation of dermatoscopic features of vitiligo with disease activity
Not Applicable
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2021/07/034757
- Lead Sponsor
- Department of Dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. A clinical diagnosis of vitiligo (segmental or non-segmental type)
2. Active disease defined as VIDA score of 4+
3. Two independent areas/lesions of of size 2 x 2 cm to 6 x 6 cm showing clinical signs of progressive vitiligo
4. Patients who are yet to be initiated on medical management. A wash off period of 4 weeks for topical and 12 weeks for systemic treatment will be ensured.
Exclusion Criteria
1. Stable disease
2. Patients with only mucosal vitiligo
3. Patients receiving phototherapy or surgical management
4. Patients who refuse to give consent for participation in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To sequentially determine the dermatoscopic features of vitiligoTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks
- Secondary Outcome Measures
Name Time Method 1. To correlate the dermatoscopic features with disease activity assessed by means of VIDA and VASI. <br/ ><br>2. To correlate the dermatoscopic features of repigmentation with treatment modality used.Timepoint: 4 months